Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume II-Reference-Cited by-同舟云学术

Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume II

Published:2023-03-15 Issue:6 Volume:24 Page:5621
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Kutner Andrzej¹^ORCID,Brown Geoffrey²^ORCID,Kallay Enikö³^ORCID

Affiliation:

1. Department of Drug Chemistry, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha, 02-097 Warsaw, Poland

2. School of Biomedical Sciences, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK

3. Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria

Abstract

The highly successful previous Volume 1 [...]

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/24/6/5621/pdf

Reference26 articles.

1. Kutner, A., Brown, G., and Kallay, E. (2023, March 03). International Journal of Molecular Sciences, Special Issue “Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers”. Available online: https://www.mdpi.com/journal/ijms/special_issues/ACCORD2021.

2. Kutner, A., Brown, G., and Kallay, E. (2022). Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers, MDPI. Available online: https://www.mdpi.com/books/book/5818-novel-strategies-in-the-development-of-new-therapies-drug-substances-and-drug-carriers.

3. Brown, G. (2022). Antagonizing RARγ Drives Necroptosis of Cancer Stem Cells. Int. J. Mol. Sci., 23.

4. Jurutka, P.W., di Martino, O., Reshi, S., Mallick, S., Sausedo, M.A., Moen, G.A., Lee, I.J., Ivan, D.J., Krall, T.D., and Peoples, S.J. (2022). An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene. Int. J. Mol. Sci., 23.

5. Witkowski, J., Polak, S., Rogulski, Z., and Pawelec, D. (2022). In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part I. Int. J. Mol. Sci., 23.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume II;International Journal of Molecular Sciences;2023-03-15